Recurrent 8q13.2-13.3 microdeletions associated with Branchio-oto-renal syndrome are mediated by human endogenous retroviral (HERV) sequence blocks by Xiaoli Chen et al.
Chen et al. BMC Medical Genetics 2014, 15:90
http://www.biomedcentral.com/1471-2350/15/90RESEARCH ARTICLE Open AccessRecurrent 8q13.2-13.3 microdeletions associated
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Background: Human endogenous retroviral (HERV) sequences are the remnants of ancient retroviral infection and
comprise approximately 8% of the human genome. The high abundance and interspersed nature of homologous
HERV sequences make them ideal substrates for genomic rearrangements. A role for HERV sequences in mediating
human disease-associated rearrangement has been reported but is likely currently underappreciated.
Methods and Results: In the present study, two independent de novo 8q13.2-13.3 microdeletion events were
identified in patients with clinical features of Branchio-Oto-Renal (BOR) syndrome. Nucleotide-level mapping
demonstrated the identical breakpoints, suggesting a recurrent microdeletion including multiple genes such as
EYA1, SULF1, and SLCO5A1, which is mediated by HERV1 homologous sequences.
Conclusions: These findings raise the potential that HERV sequences may more commonly underlie recombination
of dosage sensitive regions associated with recurrent syndromes.
Keywords: De novo 8q13.2-13.3 microdeletion, Human endogenous retroviral (HERV) sequences, Branchio-oto-renal
syndrome, Mesomelia-synostoses syndromeBackground
Low-copy repeat (LCR) or segmental duplication (SD)-
mediated non-allelic homologous recombination (NAHR)
is a common mechanism that results in microdeletions or
microduplications [1]. Many of these rearrangements are
responsible for human genomic disorders [2,3]. Typically
SDs range from 10 to hundreds of kilobases with >95% se-
quence identity and are involved in chromosomal recom-
bination [4]; this usually occurs in a constrained footprint
[5]. Indeed, smaller interspersed repeats like LINE, Alu, and
human endogenous retrovirus (HERV) elements have also
been shown to mediate recurrent genomic rearrangements* Correspondence: cxlwx@sina.com; Yiping.Shen@childrens.harvard.edu
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unless otherwise stated.[5,6]. For example, whole genome analysis showed
that >16% of HERV-K elements have undergone rear-
rangements that result in larger-scale deletion/duplication
and chromosome reshuffling in primate genomes [7]. In
addition, homologous recombination between HERV15
elements on the Y chromosome mediates a recurrent Y
chromosome microdeletion which removes the azoosper-
mia factor a (AZFa) region that results in male infertility
[8,9]. Finally, a recurrent translocation between 4q35.1
and 18q22.3 mediated by HERV-H recombination also has
been reported recently [10].
Branchio-oto-renal syndrome (BOR, OMIM 113650)
is an autosomal dominant disorder characterized by sen-
sorineural, conductive, or mixed hearing loss, structural
defects of the outer, middle, and inner ear, branchial fis-
tulas or cysts, and renal abnormalities ranging from mild
hypoplasia to complete absence [11]. The estimated
prevalence of BOR syndrome is 1:40,000 and it affectstd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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http://www.biomedcentral.com/1471-2350/15/90approximately 2% of profoundly deaf children [12,13]. This
syndrome is clinically and genetically heterogeneous and
has a high penetrance with variable expressivity [11,13].
Mutations on the human ortholog of the Drosophila eyes
absent gene (EYA1, OMIM 601653) are considered to be a
major cause of BOR syndrome. Approximately 40% of
BOR patients have mutations in the EYA1 gene; 117 differ-
ent heterozygous pathogenic variants including frame
shift, stop, splice-site, and missense mutations have been
reported [14-18]. Large heterozygous deletions at 8q13.2-
13.3 encompassing the EYA1 gene have also been detected
in patients with BOR [19-21]. Here we report two inde-
pendent de novo 8q13.2-13.3 microdeletion events in two
patients with clinical features of BOR. We provide evi-
dence that this microdeletion is recurrent and mediated
by HERV1 homologous sequences. Given that HERV se-
quences comprise approximately 8% of the human gen-
ome, our findings support the potential for these
sequences to have a broader role in mediating recurrent
disease-associated recombinations and polymorphic rear-
rangements on a genome-wide scale.
Methods
The Capital Institute of Pediatrics Review Board and the
Mayo Clinic Institutional Review Board approved this
project. The Written informed consent was obtained
from the patient’s guardian/parent/next of kin for the
publication of this report and any accompanying images.
The physical and neurological examinations by a devel-
opmental specialist as well as biochemical and other med-
ical evaluations were completed on case 1 at the Affiliated
Children’s Hospital of Capital Institute of Pediatrics. IQ
was measured by Wechsler Intelligence Scale for Children
(WISC). Phenotype information regarding case 2 was sup-
plied by the Mayo Clinic Cytogenetics Laboratory at the
time of clinical chromosomal microarray testing.
DNA from peripheral blood was isolated by the Blood
and Tissue kit (Qiagen, Valencia, CA). Array CGH was
performed using Agilent 244 K and 180 K oligonucleo-
tide platform (Agilent Technologies Inc., Palo Alto, CA)
for case 1 and 2, respectively.
Long-range PCR (Platinum PCR SuperMix High Fidelity
kit, Invitrogen, Carlsbad, CA) was performed to locate the
junction regions using multiple breakpoint-specific primers
around the approximate breakpoints (Additional file 1:
Table S1). The nested PCR was performed to confirm the
deletion breakpoints in the two independent deletion
cases. During the nested PCR, a 6.5 kb fragment outside
two HERV blocks was first amplified from the long-range
PCR products using the junction primers (1F and 1R in
Additional file 1: Table S1) [22]. The 6.5 kb fragment was
then purified from agarose gels using the QIAquick gel ex-
traction kit (Qiagen, Valencia, CA) and diluted 1:10 to be
used as the template for the second-round PCR (primers2F and 2R in Additional file 1: Table S1). The junction frag-
ment was, visualized on a 1% agarose gel, purified using
Exonuclease I (New England Biolabs Inc., MA, USA), and
then cloned into a TOPO-TA vector for Sanger sequencing
following the manufacturer’s protocol. A mixture of DNA
from 10 normal children was used as the control.
Results
Clinical reports
Case 1 is a Chinese girl born to unrelated parents. Prenatal
development was normal except for ultrasound detection
of a cyst in the left kidney at 35 gestational weeks. She was
born at 40 gestational weeks by Cesarean section with a
birth weight of 4 kg and a birth length of 50 cm. The Apgar
scores were normal at both one and five minutes after
birth. Abnormal hearing was noticed at newborn hearing
screening. At three months of age, an initial CT scan di-
agnosed bilateral cochlear dysplasia with incompletely
formed cochlea and posterior semicircular. At two years
old, an auditory brainstem response (ABR) test con-
firmed moderate conductive hearing loss in both ears.
On physical examination at four years of age, she was
110 cm (97th centile) and 16 kg (25-50th centile). The renal
ultrasound showed bilateral hydronephrosis/pyelectasis.
A routine urine test was negative and the levels of
serum urea nitrogen (3.1umol/L, normal range is 2.50-
8.21 mmol/L) and creatinine (53.2umol/L, normal range is
53–114.9umol/L) were consistent with normal renal func-
tion. Her second temporal CT scan performed at the age
of two years showed bilateral inner ear malformations
with cochlear hypoplasia (approximately 2 turns), incom-
pletely formed lateral semicircular canal, enlargement of
vestibular window and dilation of the right vestibular
aqueduct. The images also manifested deep middle fossa.
Her motor and neurological developmental skills were
normal (IQ = 83) with the exception of language delay (vo-
cabulary developmental index = 67) due to hearing loss.
The dysmorphic features included high arched palate,
branchial anomalies and a preauricular pit, and a cup-
shape to the left low-set ear (Figure 1). The karyotype was
normal 46, XX.
Case 2 is a two months old Middle Eastern male baby
born to parents who are not documented to be related.
Medical exam showed short stature, dysmorphic features
including macrocephaly, malformed and low set ears,
high arched palate, short neck, wide spaced eyes, and flat
occiput. The karyotype was 46, XY. He was noted to
have ear anomalies, although whether he has hearing
loss is unknown based on the available information in
his medical record.
Array-CGH
A 2.6 Mb microdeletion located at 8q13.2-13.3 was de-
tected in both case 1 (chr8:70,062,624-72,714,795 in
Figure 1 The dysmorphic facial features of case 1 with de novo
8q13.2-13. microdeletion. Low-set ears with an asymmetrical,
cup-shape on the left and preauricular pits near the right ear (black
arrow), and bilateral hearing loss.
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http://www.biomedcentral.com/1471-2350/15/90genome build hg18) and case 2 (chr8:70,062,624-72,738,255
in genome build hg18, Figure 2A). Parental testing con-
firmed they were both de novo deletions; array CGH and
real-time quantitative PCR were employed in case 1 while
FISH (BAC probe RP11-744 N15) was used for case 2.
There are ten Refseq genes (LOC100505718, SULF1,
SLCO5A1, PRDM14, NCOA2, TRAM1, LOC286190,
LACTB2, XKR9, EYA1, Figure 2B) in this region and six
genes reported in OMIM (SULF1, SLCO5A1, PRDM14,
NCOA2, TRAM1, EYA1). In addition, one BOR patient
reported by Sanchez-Valle et al. (chr8:70,053,688-
72,748,049 in genome build hg18) [22], and two cases in
The International Standards for Cytogenomic Arrays
Consortium (ISCA) dataset (http://www.iccg.org/;
nssv578278 at chr8:69,400,250-72,388,412 and nssv584060 at
chr8:70,062,670-72,714,817) had a similar size (Figure 2B). It
is of note that another case in the ISCA dataset, ns1494921,
is the same case as case 2 in our study. All five independent
cases share similar breakpoints (labelled * in Figure 2B), sug-
gesting the recurrent nature of this deletion.Breakpoint mapping
The breakpoint-specific primer pair (BP-3 F and BP-3R
in Additional file 1: Table S1) revealed an identical
8.5 kb amplicon in both case 1 and 2 which was notpresent in the control. To demonstrate the recurrent na-
ture of the deletions and to understand their molecular
mechanism, the junction region was mapped using long-
range PCR and nested PCR design (The locations of the
primers are shown in Figure 3A). Using the primer pair
described in Sanchez-Valle et al. (1F and 1R in Additional
file 1: Table S1, black dots in Figure 3A), an identical
6.5 kb junction fragment was also amplified in both cases
(lane 3 and 4 in Figure 3B). This fragment is the same size
as what was amplified in patient 1 in the report by
Sanchez-Valle et al. [22]. Similarly, no amplification was
detected for mixed control DNA. Thus, the junction se-
quences are deletion specific and two patients share simi-
lar breakpoints.
The nested PCR was performed (2F and 2R in Additional
file 1: Table S1, brown and blue dots in Figure 3A) using
the 6.5 kb junction sequence as a template. An 800 bp
fragment was amplified from both cases (lane 11, 12 in
Figure 3B). The sequences of the primer 2F is not
unique in the human genome, and so an 800 bp product
was generated in the control as expected when genomic
DNA was used as the template (lane 7–9 in Figure 3B).
The sequence of the 800 bp product revealed that two
human endogenous retroviral sequence blocks (HERVH-
int1, chr8:70,048,221-70,051,505 and HERVH-int2, chr8:72,
750,179-72,753,246, identify is >95%, Figure 3A) are involved
in this deletion. Using four locus-specific SNPs of the two
HER regions (labeled black in Figure 4A, highlighted blue
in Figure 4B) and two common SNPs (rs4737265 and
rs28792781, red font in Figure 4B) as landmarks, the dele-
tion breakpoints were narrowed to two 86 bp intervals
(highlighted yellow in Figure 4B) which are identical be-
tween the two adjacent HERV blocks (chr8:70,050,798-
70,050,884 and chr8:72,752,537-72,752,623).
Discussion
Human Endogenous Retroviral (HERV) sequences, which
are remnants of past retroviral infection, make up approxi-
mately 8% of the human genome [23]. The interspersed na-
ture and high sequence homology of HERVs make them
ideal substrates for NAHR in the human genome [24]. In
fact, greater than 16% of human HERV-K elements may
have mediated large-scale genome rearrangements during
primate evolution [7], and inverted HERV-K elements are
known to cause the frequent 8p23.1 polymorphic inver-
sions in humans [25]. It is known that homologous recom-
bination between distant HERVs can cause inherited male
infertility due to loss of the 792-kb fragment encompassing
azoospermia factor a (AZFa) region [8,9]. Sanchez-Valle
et al. reported the first BOR patient with 8q13.2-13.3dele-
tion and proposed that this microdeletion was mediated
by two adjacent HERV blocks [22]. A genome-wide copy
number variant analysis was performed for a Branchio-
oto-renal syndrome cohort with negative pathogenic
Figure 2 Recurrent, de novo 8q13.2-13.3 microdeletion identified in four cases with Branchio-oto-renal syndrome. A Array data plots
showing 2.6 Mb deletions ranging from 70,062,624-72,714,795 at 8q13.2-13.3 in cases 1 and 2. B The UCSC Genome Browser custom tracks
(chr8:69,393,700-73,407,100, genome build hg18) demonstrating deletion of 8q13.2-13.3 in five unrelated cases with BOR syndrome/hearing
problems (labeled as *), which cover 10 Refseq genes (LOC100505718, SULF1, SLCO5A1, PRDM14, NCOA2, TRAM1, LOC286190, LACTB2, XKR9, EYA1).
Red indicates deletion and blue indicates duplication. Note: ns1492921 in the ISCA data represents the same case as case 2 in this study.
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Figure 3 Nucleotide-level mapping of the recurrent 8q13.2-13.3 deletions. A Schematic figure of mapping primers used in long-range and
nested PCR. The numbers are the coordinate of chromosome 8 (gnome build hg18). HERVH are presented as two red rectangles (HERVH-int1
and HERVH-int2). The black lines represent the genomic size of the 8q13 region. The green and blue lines represent the size of the amplicons
produced by the long-range and nested PCR, respectively. The small brown and blue dots in the red rectangles represent the primers 2F and 2R,
and the larger black dots represent the primers 1F and 1R. While primer 1F and 1R, 2R are unique sequences in the human genome, the 2F is
scattered sequence in the human genome but is unique for the amplicon produced by the nested PCR. The 800 bp fragment produced in the
nested PCR was also amplified in the control due to two identical sequences of the 2F primer in HERVH-int1 and HERVH-int2 (two brown dots in
two HERVH blocks). B Gel electrophoresis images (0.8% agarose) of PCR products from the two cases and a control. P1: case 1, P2: case 2, C: mixed
DNA from 10 controls. Lane 1–2: DNA marker ladder (M); Lane 3–5: long-range PCR products using genomic DNA with primer 1F and 1R; Lane
7–9: general PCR products using genomic DNA with primer 2F and 2R; Lane 11–12: nested PCR products using the amplicon in lanes 3 (P1-1) and 4
(P2-1) as template with primers 2F and 2R; Lane 6 and 10: blanks.
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http://www.biomedcentral.com/1471-2350/15/90mutation in known BOR-causing genes [26]. Four car-
riers with 8q13.2-13.3 deletions (2.7 Mb deletion,
chr8:70053668–72748108) were identified that share
approximatly identical breakpoints covering HERV blocks,
proving 8q13.2-13.3 deletion is a recurrent genomic re-
arrangement event.
In the current study, we mapped the breakpoint of
8q13.2-13.3 deletions in two unique cases, and found the
breaks occurred in identical 86 bp homologous sequence
within HERV regions. We therefore demonstrated that
8q13.2-13.3 deletions associated with BOR syndrome fea-
tures can be recurrent through an NAHR mechanism,
which places this microdeletion syndrome into the samecategory as DiGeorge syndrome and William’s syndrome.
Similarly, HERV sequences were reported to mediate recur-
rent 3q13.2-q13.31 deletions which cause a new syndrome
of hypotonia and motor, language, and cognitive delays
[27]. Beside such inter-chromosomal arrangements, 150 bp
homologous sequences of two HERV-H blocks have been
shown to mediate a recurrent intra-chromosomal trans-
location between 4q and 18q [10]. The above published
studies and our results suggest that HERV regions can in-
duce both inter-chromosomal and intra-chromosomal
rearrangements.
8q13.2-13.3 microdeletion has been associated with
several medical disorders due to haploinsufficiency of
Figure 4 The sequence characteristics of the breakpoint junction in the recurrent 8q13.2-13.3 deletion. A The raw sequence data from
the 800 bp-size breakpoint junction. The black lines beneath the base calls represent four locus-specific SNPs used as landmarks in the breakpoint
identification. First two SNPs (C and G) are located in HERVH-int1 and the latter two SNPs (G and C) are located in HERVH-int 2. B Alignment of
the junction sequences from case 1 and 2. BLAST was used to compare the partial sequences of two HERV blocks (chr8:70,050,761-70,050,910,
chr8:70,2752,500-72,752,649) with the 800 bp of nested PCR product. The four locus-specific SNP that differentiate the HERV blocks are highlighted
in blue while two common SNPs are shown in red. The 87 bp recombination region is highlighted in yellow.
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http://www.biomedcentral.com/1471-2350/15/90genes within the region. Deletion of EYA1 is associated with
BOR syndrome [11,19,20,28]. The typical manifestations of
BOR are hearing loss and structural defects of the outer,
middle, and inner ear (98.5%), preauricular pits (83.6%),
branchial anomalies (68.5%), renal anomalies (38.2%), and
external ear abnormalities (31.5%) [11]. 8q13 has also re-
portedly been associated with Mesomelia-Synostoses syn-
drome (MSS, OMIM 600383) due to the co-deletion of
SULF1 and SLCO5A1 [29]. MSS is a rare dominantly inher-
ited disorder characterized by mesomelic limb shorteningTable 1 Clinical findings in six patients with recurrent 8q13.2
Case 1 in
this study
Case 2 in th
study
Major BOR criteria Hearing loss/impairment + NA
Branchial fistulae + NA




Minor BOR criteria Ear anomalies or ear
symptoms (cup ear,















Speech/language delay + NA
Short stature - Proportiona
stature
Only patient with detailed clinical information was recruited; +: present; −: absent; N
**Three patients reported by Brophy PD et al., one patient’s (CDS2893) clinical inforand acral synostoses, renal malformations and/or con-
genital heart defects occur sporadically. Hearing loss
has not been reported in MSS patients [30,31], although <10
patients with MSS have been described [29,32]. We
summarized the clinical phenotypes of reported carriers
with 8q13.2-13.3 microdeletion carriers reported in the
literatures (Table 1) [22,26]. Neither mesomelic short
stature nor severe skeletal changes was observed. Their
predominant clinical features include hearing loss (4/6),
branchial fistulae (5/6), preauricular pits (4/6) and-13.3 deletion
is Patient 1* 21230** 20960** 518240**
+ - + +
+ + + +
+ + - +
+ + - +











+ - - -
+ - - -
l short Proportional short
stature
- - -
A: not available in the medical record; *Reported by Sanchez-Valle et al.;
mation wasn’t available.
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http://www.biomedcentral.com/1471-2350/15/90hydronephrosis/kidney agenesis (4/6), which are major
suggestive phenotypes of BOR syndrome. Our literature
review suggests that recurrent 8q13.2-13.3 deletion is
an important cause of BOR. However, not all BOR cases
result from recurrent 8q13.2-13.3 deletion by a HERV
mediated non-allelic homologous recombination mech-
anism. Some BOA patients have non-recurrent alterna-
tions, such as the EYA1 exonic deletion, exemplified by
case nssv525813 in the ISCA dataset (Figure 2B). Based
on published diagnostic scoring criteria for BOR [16],
case 1 in this study and four patients in the literatures
meet the definition of typical BOR (hearing loss and
preauricular pits, inner ear and renal anomalies), while
case 2 in this study represents atypical BOR (ear anom-
alies or ear symptoms). Thus the results are consistent
with phenotype heterogeneity of the 8q13.2-13.3 dele-
tion. The functional polymorphism of the EYA1 hemizy-
gous allele or another dosage sensitive gene in the
deleted region could potentially be responsible for the
phenotype heterogeneity.
Conclusion
In summary, we confirmed in two cases the recurrent
nature of two 8q13.2-13.3 microdeletion associated with
BOR syndrome. We also mapped the deletion break-
points and demonstrated that the deletion is mediated
by two adjacent HERVH sequences. Therefore, this
microdeletion represents another example of HERV-
mediated NAHR, indicating a more prominent role for
the HERV regions in recurrent genomic disorders.
Additional file
Additional file 1: Table S1. Primers used for long-range PCR and
nested PCR.
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